CDTX Quote, Trading Chart, Cidara Therapeutics Inc.
home / stock / cdtx / cdtx quote
$2.43 Last:
-1.62% Change Percent:
$2.5 Open:
$2.43 Previous Close:
$2.54 High:
$2.38 Low:
739,693 Volume:
02/24/2021 04:55:26 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-02-24 | 2.5 | 2.43 | 2.54 | 2.38 | 739,693 |
| 2021-02-23 | 2.51 | 2.47 | 2.595 | 2.3 | 1,566,669 |
| 2021-02-22 | 2.7585 | 2.61 | 2.7585 | 2.58 | 1,358,439 |
| 2021-02-19 | 2.72 | 2.76 | 2.8499 | 2.6 | 1,761,878 |
| 2021-02-18 | 2.8635 | 2.64 | 2.99 | 2.59 | 2,144,774 |
| 2021-02-17 | 2.92 | 3.01 | 3.12 | 2.72 | 3,749,043 |
| 2021-02-16 | 2.58 | 2.9 | 3.15 | 2.5 | 7,298,580 |
| 2021-02-15 | 2.48 | 2.55 | 2.58 | 2.45 | 903,331 |
| 2021-02-12 | 2.48 | 2.55 | 2.58 | 2.45 | 900,730 |
| 2021-02-11 | 2.73 | 2.43 | 2.79 | 2.41 | 2,038,511 |
| 2021-02-10 | 2.79 | 2.58 | 2.87 | 2.55 | 1,381,534 |
| 2021-02-09 | 2.59 | 2.67 | 2.7 | 2.57 | 1,086,419 |
| 2021-02-08 | 2.55 | 2.55 | 2.68 | 2.4 | 1,926,549 |
| 2021-02-05 | 2.63 | 2.49 | 2.64 | 2.42 | 1,640,828 |
| 2021-02-04 | 2.7 | 2.66 | 2.71 | 2.55 | 404,868 |
| 2021-02-03 | 2.67 | 2.61 | 2.69 | 2.545 | 285,513 |
| 2021-02-02 | 2.63 | 2.66 | 2.6711 | 2.475 | 395,456 |
| 2021-02-01 | 2.45 | 2.59 | 2.605 | 2.38 | 614,380 |
| 2021-01-29 | 2.33 | 2.45 | 2.64 | 2.33 | 1,368,196 |
| 2021-01-28 | 2.48 | 2.35 | 2.48 | 2.31 | 430,558 |
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
UTILITY Therapeutics Joins Antimicrobials Working Group PR Newswire WASHINGTON , Feb. 17, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of UTILITY therapeutics Ltd. (UTILITY) to its coalition of companies with the missio...
-
SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced data from three posters at th...
-
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced an oral presentation and four...